You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Express Scripts
McKesson
Boehringer Ingelheim
Medtronic
Moodys
McKinsey

Last Updated: April 11, 2021

DrugPatentWatch Database Preview

Litigation Details for H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)

Docket   Start Trial Date Filed 2018-01-11
Court District Court, D. Delaware Date Terminated
Cause 35:271 Patent Infringement Assigned To Leonard Philip Stark
Jury Demand Defendant Referred To
Parties ZYDUS PHARMACEUTICALS (USA) INC.
Patents 7,144,884; 8,476,279; 8,722,684; 8,969,355; 9,125,908; 9,125,909; 9,125,910; 9,227,946; 9,278,096; 9,861,630
Attorneys Kenneth Laurence Dorsney
Firms Connolly Gallagher LLP
Link to Docket External link to docket
Small Molecule Drugs cited in H. Lundbeck A/S v. Lupin Limited
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for H. Lundbeck A/S v. Lupin Limited (D. Del. 2018)

Date Filed Document No. Description Snippet Link To Document
2018-03-27 15 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,861,630 B1; . (Noreika, Maryellen… 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-05-14 250 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,722,684 B2 ;8,969,355 B2 ;9,227,946… 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-05-31 280 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,144,884 ;8,476,279 ;8,722,684… 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2018-07-09 31 Scheduling Order - Patent allegation of infringement of United States Patent Nos. 7,144,884, 8,476,279, 8,722,684 8,969,355, 9,227,946…asserted patents it alleges are infringed and produce the file history for each asserted patent, pursuant…Identification of Accused Products and Asserted Patents. By July 13, 2018, Plaintiffs shall identify…invalidating references (e.g., publications, manuals, and patents), pursuant to D. Del. Default Standard Paragraph…same issue for more than one of the asserted patents shall count as one Interrogatory. An Interrogatory External link to document
2019-06-14 312 Patent/Trademark Report to Commissioner of Patents the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,125,908 B2 ;9,125,909 B2 . … 12 January 2018 1:18-cv-00088 Patent - Abbreviated New Drug Application(ANDA) Defendant External link to document
2019-07-05 337 Redacted Document Nos. 8,722,684 (“the ’684 Patent”); 8,969,355 (“the ’355 Patent”); 9,227,946 (“the ’946 Patent”); and… United States Patent Nos. 8,722,684 (“the ’684 patent”), 8,969,355 (“the ’355 patent”), 9,227,946 (… (“the ’946 patent”), 9,861,630 (“the ’630 patent”), 9,125,910 (“the ’910 patent”), and 9,278,096 (“… (INVALIDITY OF THE ’910 PATENT) The claims of the ’910 patent are invalid and/or unenforceable… (INVALIDITY OF THE ’096 PATENT) The claims of the ’096 patent are invalid and/or unenforceable External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKinsey
Merck
Moodys
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.